Skyrizi notches top pharma, Rx brand spot for Q3 2024

Skyrizi notches top pharma, Rx brand spot for Q3 2024

Source: 
Medical Marketing and Media
snippet: 


The season of Skyrizi continues as the treatment for psoriasis, Crohn’s disease and psoriatic arthritis from AbbVie notched the latest quarterly crown for over-the-counter (OTC) pharma and Rx brands.